LIF–STAT3 signaling suppresses PPARα to cause lipid imbalance, while fenofibrate restores lipid homeostasis and reduces cachexia, and PPARδ activation enhances oxidative metabolism and muscle endurance (112–114). Here, STAT3 is linked to Cachexia.